In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....